| dc.contributor.author | López Suárez, Patricia | |
| dc.contributor.author | González Rodríguez, Irene | |
| dc.contributor.author | Sánchez García, Borja | |
| dc.contributor.author | Gueimonde Fernández, Miguel | |
| dc.contributor.author | Margolles Barros, Abelardo | |
| dc.contributor.author | Suárez Díaz, Ana María | |
| dc.date.accessioned | 2013-01-30T10:16:26Z | |
| dc.date.available | 2013-01-30T10:16:26Z | |
| dc.date.issued | 2012 | |
| dc.identifier.citation | Vaccine, 30(5), p. 825–829 (2012); doi:10.1016/j.vaccine.2011.11.115 | spa |
| dc.identifier.issn | 0264-410X | |
| dc.identifier.uri | http://hdl.handle.net/10651/9981 | |
| dc.description.sponsorship | This work was financed by European Union FEDER funds and the Spanish Plan Nacional de I+D (grants AGL2007-61805 and AGL2010-14952). IG was the recipient of an FPI Grant, and BS was the recipient of a Juan de la Cierva postdoctoral contract, both from the Spanish Ministerio de Ciencia e Innovación(MICINN). | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Vaccine, 30(5) | |
| dc.rights | © 2011 Elsevier Ltd | |
| dc.source | SCOPUS | eng |
| dc.title | Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy | eng |
| dc.type | journal article | |
| dc.identifier.local | 20111926 | spa |
| dc.identifier.doi | 10.1016/j.vaccine.2011.11.115 | |
| dc.relation.projectID | MEC/AGL2007-61805 | |
| dc.relation.projectID | MEC/AGL2010-14952 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1016/j.vaccine.2011.11.115 | eng |
